BDX · 8-K · 20260806PR053790

Geographic Market Commentary

BECTON DICKINSON & CO · 2026-08-06 · Importance 36 · Surprise 40

United States revenue increased 6.9% year over year to $3,081 million on both a reported and foreign-currency-neutral basis. International revenue rose 3.2% to $1,902 million as reported, but increased only 0.6% on a foreign-currency-neutral basis. International performance varied by business, with Advanced Patient Monitoring up 17.8% FXN and Surgery up 11.7% FXN, while BioPharma Systems declined 6.2% FXN and Medication Delivery Solutions declined 4.7% FXN.

Key facts

• United States revenues for the three months ended June 30, 2026: $3,081 million, a 6.9% increase versus prior year. source
• International revenues for the three months ended June 30, 2026: $1,902 million, a 3.2% increase reported and 0.6% FXN. source